Jiangsu Bioperfectus Technologies Management
Management criteria checks 2/4
Jiangsu Bioperfectus Technologies' CEO is Guoqiang Wang, appointed in Mar 2017, has a tenure of 7.75 years. directly owns 8.72% of the company’s shares, worth CN¥340.87M. The average tenure of the management team and the board of directors is 5.3 years and 1.8 years respectively.
Key information
Guoqiang Wang
Chief executive officer
CN¥2.1m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 7.8yrs |
| CEO ownership | 8.7% |
| Management average tenure | 5.3yrs |
| Board average tenure | 1.8yrs |
Recent management updates
Recent updates
CEO
Guoqiang Wang (54 yo)
7.8yrs
Tenure
CN¥2,116,976
Compensation
Dr. Guoqiang Wang is Chairman & GM of Jiangsu Bioperfectus Technologies Co. Ltd. from September 19, 2023. Dr. Wang was Vice Chairman & GM of Jiangsu Bioperfectus Technologies Co. Ltd.from March 2017 to Se...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & GM | 7.8yrs | CN¥2.12m | 8.72% CN¥ 340.9m | |
| Deputy GM | 7.8yrs | CN¥1.64m | 2.56% CN¥ 100.3m | |
| Deputy GM | 2yrs | CN¥1.49m | no data | |
| Deputy General Manager of R&D Center | 2.9yrs | CN¥1.63m | no data |
5.3yrs
Average Tenure
54yo
Average Age
Experienced Management: 688399's management team is seasoned and experienced (5.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & GM | 1.3yrs | CN¥2.12m | 8.72% CN¥ 340.9m | |
| Deputy GM | 7.8yrs | CN¥1.64m | 2.56% CN¥ 100.3m | |
| Deputy GM | 1.8yrs | CN¥1.49m | no data | |
| Director | no data | CN¥2.45m | no data |
1.8yrs
Average Tenure
54.5yo
Average Age
Experienced Board: 688399's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 11:04 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Jiangsu Bioperfectus Technologies Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|